KOREA ARLICO PHARM CO.,LTD. Logo

KOREA ARLICO PHARM CO.,LTD.

Develops, manufactures, and sells generic and other pharmaceutical products.

260660 | KO

Overview

Corporate Details

ISIN(s):
KR7260660006
LEI:
Country:
South Korea
Address:
서울특별시 서초구 바우뫼로27길 7-21 (양재동), 서초구

Description

Korea Arlico Pharm Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes prescription (ETC) and over-the-counter (OTC) drugs, medical devices, and oriental medical preparations, with a specialization in generic pharmaceuticals. Operating from a KGMP-certified facility, it focuses on continuous innovation to improve human health. The company serves its domestic market and exports its products to numerous countries, with the goal of expanding its global presence.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-02-08 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.5 KB
2023-01-03 00:00
[기재정정]현금ㆍ현물배당결정
Korean 13.2 KB
2022-12-27 00:00
주식등의대량보유상황보고서(일반)
Korean 128.0 KB
2022-12-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2022-12-15 00:00
현금ㆍ현물배당결정
Korean 8.8 KB
2022-11-24 00:00
기업설명회(IR)개최
Korean 7.1 KB
2022-11-18 00:00
전환가액의조정
Korean 11.3 KB
2022-11-09 00:00
분기보고서 (2022.09)
Korean 644.6 KB
2022-10-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2022-08-18 00:00
전환가액의조정
Korean 10.9 KB
2022-08-12 00:00
[기재정정]사업보고서 (2021.12)
Korean 923.6 KB
2022-08-12 00:00
반기보고서 (2022.06)
Korean 630.1 KB
2022-07-04 00:00
주식등의대량보유상황보고서(일반)
Korean 158.0 KB
2022-05-30 00:00
전환가액의조정
Korean 10.5 KB
2022-05-25 00:00
기업설명회(IR)개최
Korean 7.0 KB

Automate Your Workflow. Get a real-time feed of all KOREA ARLICO PHARM CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOREA ARLICO PHARM CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOREA ARLICO PHARM CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.